| Neuroinflammation in neurodegenerative disorders—a review M Schain, WC Kreisl Current neurology and neuroscience reports 17, 1-11, 2017 | 326 | 2017 |
| Increased basal ganglia binding of 18F‐AV‐1451 in patients with progressive supranuclear palsy R Smith, M Schain, C Nilsson, O Strandberg, T Olsson, D Hägerström, ... Movement Disorders 32 (1), 108-114, 2017 | 131 | 2017 |
| Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [11C] vinpocetine B Gulyás, M Tóth, M Schain, A Airaksinen, Á Vas, K Kostulas, P Lindström, ... Journal of the neurological sciences 320 (1-2), 110-117, 2012 | 118 | 2012 |
| Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C] PBR28 K Collste, P Plavén-Sigray, H Fatouros-Bergman, P Victorsson, M Schain, ... Molecular psychiatry 22 (6), 850-856, 2017 | 110 | 2017 |
| Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C] vinpocetine B Gulyás, Á Vas, M Tóth, A Takano, A Varrone, Z Cselényi, M Schain, ... Neuroimage 56 (3), 1111-1121, 2011 | 99 | 2011 |
| Modeling strategies for quantification of in vivo 18F-AV-1451 binding in patients with tau pathology A Hahn, M Schain, M Erlandsson, P Sjölin, GM James, OT Strandberg, ... Journal of Nuclear Medicine 58 (4), 623-631, 2017 | 68 | 2017 |
| Diurnal and seasonal variation of the brain serotonin system in healthy male subjects GJ Matheson, M Schain, R Almeida, J Lundberg, Z Cselényi, J Borg, ... Neuroimage 112, 225-231, 2015 | 67 | 2015 |
| Guidelines for the content and format of PET brain data in publications and archives: a consensus paper GM Knudsen, M Ganz, S Appelhoff, R Boellaard, G Bormans, RE Carson, ... Journal of Cerebral Blood Flow & Metabolism 40 (8), 1576-1585, 2020 | 63 | 2020 |
| In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects N Kanegawa, K Collste, A Forsberg, M Schain, R Arakawa, A Jucaite, ... Brain, behavior, and immunity 54, 149-157, 2016 | 59 | 2016 |
| Quantification of serotonin transporter availability with [11C] MADAM—a comparison between the ECAT HRRT and HR systems M Schain, M Tóth, Z Cselényi, P Stenkrona, C Halldin, L Farde, A Varrone Neuroimage 60 (1), 800-807, 2012 | 53 | 2012 |
| Validity and reliability of extrastriatal [11C] raclopride binding quantification in the living human brain JE Svensson, M Schain, P Plavén-Sigray, S Cervenka, M Tiger, M Nord, ... Neuroimage 202, 116143, 2019 | 39 | 2019 |
| Test–retest reliability of [11C]AZ10419369 binding to 5-HT1B receptors in human brain M Nord, SJ Finnema, M Schain, C Halldin, L Farde European journal of nuclear medicine and molecular imaging 41, 301-307, 2014 | 35 | 2014 |
| Evaluation of two automated methods for PET region of interest analysis M Schain, K Varnäs, Z Cselényi, C Halldin, L Farde, A Varrone Neuroinformatics 12, 551-562, 2014 | 33 | 2014 |
| Association between sumatriptan treatment during a migraine attack and central 5-HT1B receptor binding M Deen, A Hougaard, HD Hansen, M Schain, A Dyssegaard, ... JAMA neurology 76 (7), 834-840, 2019 | 30 | 2019 |
| Arterial input function derived from pairwise correlations between PET-image voxels M Schain, S Benjaminsson, K Varnäs, A Forsberg, C Halldin, A Lansner, ... Journal of Cerebral Blood Flow & Metabolism 33 (7), 1058-1065, 2013 | 30 | 2013 |
| Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT M Schain, M Tóth, Z Cselényi, R Arakawa, C Halldin, L Farde, A Varrone European journal of nuclear medicine and molecular imaging 40, 228-237, 2013 | 27 | 2013 |
| Optimal acquisition time window and simplified quantification of dopamine transporter availability using 18F-FE-PE2I in healthy controls and Parkinson disease patients I Sonni, P Fazio, M Schain, C Halldin, P Svenningsson, L Farde, ... Journal of Nuclear Medicine 57 (10), 1529-1534, 2016 | 26 | 2016 |
| Measuring endogenous changes in serotonergic neurotransmission with [11C]Cimbi-36 positron emission tomography in humans S da Cunha-Bang, A Ettrup, B Mc Mahon, AP Skibsted, M Schain, S Lehel, ... Translational psychiatry 9 (1), 134, 2019 | 25 | 2019 |
| Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with … P Fazio, M Schain, L Mrzljak, N Amini, S Nag, N Al-Tawil, CJ Fitzer-Attas, ... Neuroimage 152, 330-339, 2017 | 24 | 2017 |
| The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases R Smith, F Capotosti, M Schain, T Ohlsson, E Vokali, J Molette, ... Nature communications 14 (1), 6750, 2023 | 23 | 2023 |
Lars FardeProfessor of Psychiatry, Karolinska Institutet在 ki.se 的电子邮件经过验证
